Occudo Quantitative Strategies LP Brainstorm Cell Therapeutics Inc. Transaction History

Occudo Quantitative Strategies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$2.0 - $3.2 $48,790 - $78,064	24,395 New	24,395 $50,000
Q4 2021 Feb 14, 2022	SELL	$2.81 - $4.23 $28,572 - $43,010	-10,168 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.14 - $4.09 $31,927 - $41,587	10,168 New	10,168 $34,000
Q1 2021 May 14, 2021	SELL	$3.46 - $7.88 $313,420 - $713,801	-90,584 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.99 - $17.73 $361,430 - $1.61 Million	90,584 New	90,584 $410,000

10.9M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $39.4M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.